Purigen Biosystems Lands $18,200,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5e9e1fc4-2d31-4a37-aab6-0f8937b85319 - Date
5/18/2016 - Company Name
Purigen Biosystems - Mailing Address
7026 Koll Center Pkwy Pleasanton, CA 94566 USA - Company Description
Purigen Biosystems is redefining nucleic acid sample prep by providing an innovative platform based on the remarkably efficient isotachophoresis technology invented in the lab of Stanford University professor Juan Santiago. - Website
http://www.purigenbio.com - Transaction Type
Venture Equity - Transaction Amount
$18,200,000 - Transaction Round
Series A - Proceeds Purposes
The Series A proceeds will be used to accelerate research, development and commercialization of the Purigen benchtop technology, which involves the automated extraction and quantification of samples for genomic and genetic testing. - M&A Terms
- Venture Investor
5AM Ventures - Venture Investor
Roche Venture Fund - Venture Investor
StartX - Venture Investor
Western Technology Investment - Venture Investor
Undisclosed
